Chargement en cours...
Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma
BACKGROUND: Live attenuated influenza vaccine (LAIV) is recommended for annual influenza vaccination in children from age 2 years. However, some guidelines recommend against its use in children with asthma or recurrent wheeze due to concerns over its potential to induce wheezing. OBJECTIVE: We sough...
Enregistré dans:
| Publié dans: | J Allergy Clin Immunol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Mosby
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7156909/ https://ncbi.nlm.nih.gov/pubmed/31863808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2019.12.010 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|